CD4 and graft versus host disease: More importantly, human DCIL−10 modulate allogeneic CD4+ T cell responses in vivo in immunized humanized mice and preliminary data showed that murine DCIL−10, which share phenotypic and functional characteristics with human DCIL−10, delay mice mortality in a model of acute GvHD, dampening the clinical signs of the pathology.